Current aspects of valproate in bipolar disorder

International Clinical Psychopharmacology

Volumn 15, Issue 1, 2000, Pages 1-11

  Lennkh, C ^a   Simhandl, C ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bipolar disorder; Mania; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LITHIUM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

AGRANULOCYTOSIS; ALCOHOL ABUSE; ATAXIA; CLINICAL TRIAL; DEPRESSION; DRUG ABUSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MANIA; MANIC DEPRESSIVE PSYCHOSIS; META ANALYSIS; PANCREATITIS; PANIC; PRIORITY JOURNAL; REVIEW; SEDATION; THROMBOCYTOPENIA; TREMOR; WEIGHT GAIN;

EID: 0033978218     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200015010-00001     Document Type: Review

References (105)

1. Aagaard J, Vestergaard P (1990) Predictors of outcome in prophylaxis lithium treatment: a 2-year prospective study. J Affective Disord 18:259-266.
2. Altrup U, Gerlach H, Speckmann EJ (1992) Effects of sodium valproate in a model nervous system. Epilepsia 33:743-752.
3. Apelt S, Emrich H (1990) Sodium valproate in benzodiazepine withdrawal. Am J Psychiatry 147:950-951.
4. Apelt S, Schmauss C, Emrich H (1992) Psychopharmakologie in der Klinik der Benzodiazepin-Abhängigkeit. Fortschritte neurol Psychiatrie 60:104-109.
5. Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A (1970) Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent depressive disorders. Lancet 2:326-330.
6. Biggs CS, Pearce BR, Fowler LJ, Whitton PS (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study. J Neurochem 59:1702-98.
7. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janiak PG, Petty F, Dilsaver SC (1994) Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 271:918-924.
8. Bowden CL, Janiak PG, Orsulak P, Swann A, Davis JM (1996) Relation of serum valproate concentration to response in mania. Am J Psychiatry 153:765-770.
9. Brady KT, Sonne S, Anton R (1996) Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry.
10. Brennan MJW, Sandyk R, Borsook D (1984) Use of sodium valproate in the management of affective disorders: basic and clinical aspects. In: Anticonvulsants in affective disorders (Emrich HM, Okuma T, Müller AA, eds), Amsterdam: Elsevier, pp. 56-65.
11. Brown R (1989) US experience with valproate in manic depressive illness: a multicenter trial. J Clin Psychiatry 50:13-16.
12. Burton BS (1882) On the propylderivatives and decomposition products of ethylacetoacetate. Am Chem J 3:385-395.
13. Calabrese JR, Delucchi (1989) Phenomenology of rapid-cycling maniac depression and its treatment with valproate. J Clin Psychiatr 50:30-34.
14. Calabrese JR, Delucchi GA (1990) Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 147:431-434.
15. Calabrese JR, Markovitz PJ, Wagner SC (1991) Predictors of valproate response in rapid-cycling bipolar disorder. Biol Psychiatry 29:166-167.
16. Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC (1992) Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmakology 12:53-56.
17. Calabrese JR, Woyshille MJ, Kimmel SE, Rapport DJ (1993) Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol 13:280-283.
18. Calabrese JR, Woyshville MJ, Rapport RT (1994) Clinical efficacy of valproate. In: Anticonvulsants in mood disorders (Joffe RT, Calabrese JR, eds), New York: Dekker, pp. 131-146.
19. Delgado MR (1994) Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neural 9:311-314.
20. Denicoff KD, Smith-Jackson ES, Bryan AL, Omar Ali, Post RM (1996) Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder. Am J Psychiatry 154:1456-1458.
21. Dunner DL, Fieve RR (1974) Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 30:229-233.
22. Emilien G, Maloteaux JM, Seghers A, Charles G (1996) Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis. Eur Neuropsychopharmacol 6:245-252.
23. Emrich HM, von Zerssen D, Kissling W, Möller HJ, Windorfer A (1980) Effect of sodium valproate on mania: the GABA-hypothesis of affective disorder. Arch Psychiatr Nervenkr 229:1-16.
24. Emrich HM, von Zerssen D, Kissling W, Moller HJ (1981) On a possible role of GABA in mania: therapeutic efficacy of valproate. In: GABA and benzodiazepine rezeptors (Costa E, deChiara G, Gessa GL, eds), New York: Raven Press, pp. 287-296.
25. Emrich HM, Dose M, von Zerssen D (1985) The use of sodium valproate, carbamazepine, and oxcarbazepine in patients with affective disorders. J Affect Disord 8:243-250.
26. Emrich HM, Wolf R (1992) Valproate treatment of mania. Prog Neuro-Psychopharmacol Biol Psychiatr 16:691-701.
27. Fogelson DL, Jacobson S, Sternbach H (1991) A retrospective study of valproate in private psychiatric practice. Ann Clin Psychiatry 3:315-320.
28. Freeman WT, Clothier JL, Pazzagalia P, Lesem MD, Swann AC (1992) A double blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 149:108-111.
29. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321:489-493.
30. Goodwin FK, Jamison KR (1990) Manic depressive illness. New York: Oxford University Press, pp. 22-49.
31. Harrow M, Goldberg JF, Grossmann LS, Meltzer HY (1990) Outcome in manic disorders: a naturalistic follow-up study. Arch Gen Psychiatry 47:665-671.
32. Hayes SG (1992) Long-term valproate prophylaxis in refractory affective disorders. Ann Clin Psychiatry 4:55-63.
33. Himmelhoch JM, Garfinkel ME (1986) Sources of lithium resistance in mixed mania. Psychopharmacol Bull 22:613-620.
34. Holtzer CD, Echaves SA (1996) Valproate in the treatment of acute mania. J Pharm Technol 12:6-11.
35. Hranov LG, Krastev P, Sayan L, Stefanov S (1998) Sodium valproate, i.v. and p.o. for the treatment of acute manic episode. Abstract presented at the XXI CINP; Glasgow.
36. Jeavons PM (1982) Sodium valproate and neural tube defects. Lancet 2:1282-1283.
37. Jensen R, Brinck T, Olesen J (1994) Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled cross-over study. Neurology 44:647-651.
38. Kando JC, Tohen M, Castillo J, Zarate CA (1996) The use of valproate in an elderly population with affective symptoms. J Clin Psychiatry 57:238-240.
39. Kahn D, Stevenson E, Douglas CJ (1988) Effect of sodium valproate in three patients with organic brain syndromes. Am J Psychiatry 145:1010-1011.
40. Keck PE, McElroy SL, Tugrul KC (1993) Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 54:305-308.
41. Keller MB, Lavori PW, Coryell W, Andreasen NC, Ensicott J and Clayton PJ (1986) Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 255:3188-3142.
42. Kramer B (1990) Maintenance electroconvulsive therapy in clinical practice. Convuls Therapy 6:279-285.
43. Krauthammer C, Klerman GL (1978) Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Arch Gen Psychiatry 35:1333-1339.
44. Kukopulos A, Reginaldi D, Laddumada P, Floris G, Serra G, Tondo L (1980) Course of the manic-depressive cycle and changes caused by treatments. Neuropsychopharmacology 13:156-167.
45. Lambert PA, Cavaz G, Borselli S (1966) Action neuropsychotrope d'un nouvel anti-epileptique: le depamide. Ann Med Psychol 1:707-710.
46. Lambert PA, Borselli S, Marcou G, Cabrol G (1971) Action thymo-regulatrice a long terme de Depamide dans la psychose maniaco-depressive. Ann Med Psychol 2:442-447.
47. Lambert PA (1984) Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In: Anticonvulsants in affective disorders (Emrich HM, Okuma T, Muller AA, eds), Amsterdam: Elsevier, pp. 33-44.
48. Lambert PA, Venaud G (1987) Utilisation de valpromide en therapeutique psychiatrique. L'Encephale 8:367-373.
49. Lambert PA, Venaud G (1992) Comparative study of valpromide vs. lithium in treatment of affective disorders. Nervure 5:57-65.
50. Levy RH, Penry JK (1991) Idiosyncratic reactions to valproate: clinical risk patterns and mechanisms of toxicity. New York: Raven Press.
51. Lum M, Fontaine R, Elie R, Ontiveros A (1990) Divalproex sodium's effect in panic disorder: a placebo-controlled study. Biol Psychiatry 27:41 A-179A.
52. Maes M, Calabrese J, Jayathilake K, Meltzer HY (1997) Effects of subchronic treatment with valproate on 5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission. Psychiatry Res 71:67-76.
53. Maj M, Pirozzi R, Kemali D (1989) Long-term outcome of lithiumprophylaxis in patients initially classified as complete responders. Psychopharmacology 98:535-538.
54. Mauri MC, Percudani MG, Regazzetti MG, Altamura AC (1990) Alternative prophylactic treatments to lithium in bipolar disorders. Clin Neuropharmacol 13:90S-96S.
55. McCoy L, Vololato NA, Schwartzkopf SB, Nasrallah HA (1993) Clinical correlates of valproate augmentation in refractory bipolar disorder. Ann Clin Psychiatry 5:29-33.
56. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson LI (1988a) Valproate in the treatment of rapid-cycling bipolar disorder. J Clin Psychopharmacol 8:275-279.
57. McElroy SL, Keck PE, Pope HG Jr (1988b) Treatment of rapid cycling bipolar disorder with sodium valproate. J Clin Psychopharmacol 8:275-279.
58. McElroy SL, Keck PE, Pope HG, Hudson JI (1988c) Valproate in primary psychiatric disorders. In: Literature review and clinical experience in a private psychiatric hospital, in Use of anticonvulsants in Psychiatry (McElroy SL, Pope Jr HG, Clifton NJ, eds), Oxford: Oxford Health Care.
59. McElroy SL, Keck PE, Pope HG, Hudson JI, Morris D (1991) Correlates of antimanic response to valproate. Psychopharmacol Bull 27:127-133.
60. McElroy SL, Keck PE, Pope HG, Hudson JI (1992) Valproate in the treatment of bipolar disorder: Literature review and clinical guidelines. J Clin Psychopharmacol 12:42S-52S.
61. McElroy SL, Keck PE, Tugrul KC (1993) Valproate as loading treatment in acute mania. Neuropsychobiology 27:146-149.
62. McElroy SL, Keck Jr PE, Stanton SP (1996) A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 57:142-146.
63. McFarland BH, Miller MR, Straumfjord AA (1990) Valproate use in the older manic patient. J Clin Psychiatry 51:479-481.
64. McLean MJ, MacDonald RL (1986) Carbamazepine and 10, 11-epoxycarbamazepine produce use-and voltage dependent limitations of rapid firing action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 238:727-738.
65. Mellow AM (1993) Sodium valproate in the treatment of behavioral disturbances in dementia. J Geriatr Psych Neurol 6:205-209.
66. Miklowitz DJ, Goldstein MJ, Nuechterlein KH, Snyder KS, Mintz J (1988) Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry 45:225-231.
67. Mosolov SN, Kostiukova MV, Singin AS (1998) Open comparative clinic and pharmakokinetic study of anticonvulsants prophylactic efficacy in bipolar affective and schizoaffective disorders. Abstract presented at the XXI CINP; Glasgow.
68. Papatheodorou G, Kutcher SP, Katic M (1995) The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults. J Clin Psychopharmacol 15:110-116.
69. Petty F, Rush AJ, Davis JM, Calabrese JR, Kimmel SE, Swann AE, Bowden CL (1996) Plasma GABA predicts acute response to divalproex in mania. Biol Psychiatry 39:278-284.
70. Pope HG Jr, McElroy SL, Keck PE, Hudson JI (1991) Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 48:62-68.
71. Post RM, Leverich GS, Rosoff AS, Altshuler LL (1990) Carbamazepine prophylaxis in refractory affective disorders: a focus on longterm follow-up. J Clin Psychopharmacol 10:318-327.
72. Post RM, Ketter TA, Denicoff K, Frye MA (1996a) The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 128:115-129.
73. Post RM, Ketter TA, Pazzagalia PJ, Denikoff K (1996b) Rational polypharmacy in the bipolar affective disorders. Epilepsy 11:153-180.
74. Post RM, Leverich GS, Denicoff KD, Dunn R (1997) Alternative approaches to refractory depression in bipolar illness. Depress Anxiety 5:175-189.
75. Potter WZ, Bowden CL (1992) Valproate and mood disorders: perspectives. J Clinical Psychopharmacol 12:2S-6S.
76. Price LH, Heninger GR (1994) Lithium in the treatment of mood disorders. N Engl J Med 331:591-597.
77. Prien RF, Potter WZ (1990) NIMH workshop report on treatment of bipolar disorder. Psychopharmacol Bull 26:409-427.
78. Prien RF, Caffey EM Jr, Klett CJ (1973a) Prophylactic efficacy of lithium carbonate in manic-depressive illness: report of the Veterans Administration and National Institute of Menthal Health Collaborative Study Group. Arch Gen Psychiatry 28:337-341.
79. Prien RF, Klett CJ, Caffey EM Jr (1973b) Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 29:420-425.
80. Prien RF, Klett CJ, Caffey EM Jr (1974) Lithium prophylaxis in recurrent affective illness. Am J Psychiatry 131:198-203.
81. Prien RF (1984) NIH report: five-center study clarifies use of lithium, imipramine for recurrent affective disorders. Hosp Commun Psychiatry 35:1987-1098.
82. Prien RF, Himmelhoch JM, Kupfer DJ (1988) Treatment of mixed mania. J Affect Disord 15:9-15.
83. Primeau F, Fontaine R, Beauclair L (1990) Valproic acid and panic disorder. Can J Psychiatry 35:248-250.
84. Puzynski S, Klosiewicz L (1984) Valproic acid amide in the treatment of affective and schizoaffective disorders. J Affect Disord 6:115-121.
85. Sachs GS (1990) Use of clonazepam for bipolar disorder. J Clin Psychiatry 51:31S-34S.
86. Schaff MR, Fawcett J, Zajecka JM (1993) Divalproex sodium in the treatment of refractory affective disorders. J Clin Psychiatry 54:380-384.
87. Schou M, Juel-Nielsen L, Strömgren E, Voldby H (1954) The treatment of manic psychoses by the addition of lithium salts. J Neural Neurosurg Psychiatry 17:250-260.
88. Sharma V, Lakshmi NY, Haslam DRS, Silverstone PH, Parikh S, Matte R, et al. (1997) Continuation and prophylactic treatment of bipolar disorder. Can J Psychiatry 42:92S-100S.
89. Simhandl C, Meszaros K (1992) The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review. J Psychiatr Neurosci 17:1-14.
90. Simhandl C, Denk E, Thau K (1993) The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders. J Affect Disord 28:221-231.
91. Small JG, Klapper MH and Kellams JJ (1988) Electroconvulsive therapy compared with lithium in the management of manic states. Arch Gen Psychiatry 45:727-732.
92. Solomon D, Keitner G, Miller I, Shea M, Keller M (1995) Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry 56:5-13.
93. Sovner R (1989) The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders. J Clin Psychiatry 50:40S-43S.
94. Stallone F, Shelley E, Mendlewicz J (1973) The use of lithium in affective disorders: a double blind study of prophylaxis in bipolar illness. Am J Psychiatry 130:1006-1010.
95. Stoll AL, Banov M, Kolbrener M (1994) Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders. J Clin Psychopharmacol 14:311-313.
96. Strakowski S, McElroy SL, Keck PE (1996) Efficacy of valproate in bipolar illness: comparisons and contrasts with lithium. In: Pharmacology of mood and cognition (Montgomery S, Halbreich U, eds), Washington, DC: American Psychiatric Press
97. Strober M, Morrel W, Burroughs J (1988) A family study of bipolar I disorder to adolescence: early onset of symptoms linked to increased familial loading and lithium resistance. J Affect Disord 15:255-268.
98. Svestka J, Rysanek R, Ceskova E (1990) Sodium valproate in the treatment of endogenous depressions. Activ Nerv Super 32:231-232.
99. Swann AC, Bowden CL, Morris D, Calabrese JR (1997) Depression during mania. Arch Gen Psychiatry 54:37-42.
100. Thau K, Meszaros K, Simhandl C (1993) The use of high dosage lithium carbonate in the treatment of acute mania: a review. Lithium 4:149-159.
101. Tohen M, Waternaux CM, Tsuang MT, Hunt AT (1990) Four year follow-up of 24 first year episode manic patients. J Affect Disord 19:79-86.
102. Vahip S, Ozkan B, Ayan A (1995) Elevation of plasma lithium at the end of mania and some biochemical correlates. Presented at the 2nd International Conference on New Directions in Affective Disorders; 3-8 September; Jerusalem, Israel.
103. Walden J, Altrup U, Reith H, Speckmann EJ (1993) Effects of valproate on early and late potassium currents of single neurons. Eur Neuropsychopharmacol 3:137-141.
104. Weisler RH, Risner ME, Ascher JA (1994) Use of lamotrigine in the treatment of bipolar disorder. New Research Program and Abstracts of the 147th Annual Meeting of the American Psychiatric Association; 26 May; Philadelphia, pp. 216.
105. Wilder BJ, Karas BJ Pentry JK (1983) Gastrointestinal tolerance of divalproex sodium. Neurology 33:808-811.